Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
expected in a near future an international and interdisciplinary environment, including for example the CryoNET network, the Nordic EMBL Partnership and international collaborators. good scientific and very
-
, participation in organisations etc. Additional qualifications in relation to the position References/recommendations You can read more about the requirements for your application here . The application must be
-
the relevant union. The period of employment is 2 years. The expected start date is 1 July 2026, or according to mutual agreement. The position is a full-time position. You can read more about career paths
-
, about some of the projects Your qualifications We are looking for highly motivated candidates with a strong background in electrical engineering , ideally specialized in power electronics for energy
-
notified whether or not their applications have been sent to an expert assessment committee for evaluation. The selected applicants will be informed about the composition of the committee, and each applicant
-
notified whether or not their applications have been sent to an expert assessment committee for evaluation. The selected applicants will be informed about the composition of the committee, and each applicant
-
applicants will be notified whether or not their applications have been sent to an expert assessment committee for evaluation. The selected applicants will be informed about the composition of the committee
-
starting date on 1 August 2026 or according to mutual agreement. You can read more about career paths at DTU here . Further information Further information may be obtained from Researcher Nefeli E. Novak
-
epidemiology. The postdoc will therefore be involved in the team's projects encompassing medications specifically used by women and sex disparities in medication use. About the research environment The postdoc
-
about the department here and about the Health faculty here . DCPT is a national centre, responsible for proton therapy of all relevant Danish cancer patients, having been in operation since January 2019